Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Kezar Life Sciences is a clinical-stage biotechnology company focused on developing small molecule therapeutics for immune-mediated diseases. Its lead candidate, zetomipzomib, targets the immunoproteasome to treat autoimmune conditions like AIH and lupus. The company aims to offer broad immunomodulation with convenient dosing, leveraging proprietary IP and strategic collaborations to address high unmet medical needs in autoimmune and inflammatory disorders.
This description was generated via AI from an annual report. Updated about 1 year ago.